Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax: Experience in 26 patients / Transcatheter aortic valve implantation
Rev. méd. Chile
;
143(12): 1512-1520, dic. 2015. graf, tab
Article
Dans Espagnol
| LILACS
| ID: lil-774435
ABSTRACT
Background:
Aortic valve stenosis (AS) is the most common valvular disease. Its surgical indication is undisputed in symptomatic severe AS, however, 30% of patients are at high surgical risk or inoperable. Transcatheter Valve Implantation (TAVI) is an alternative for this group of patients.Aim:
To describe the clinical outcomes of TAVI in a group of patients treated at the Instituto Nacional del Tórax, Santiago, Chile. Patients andMethods:
Prospective study including all patients referred for TAVI due to their high surgical risk or being inoperable. All-cause mortality, secondary stroke, permanent pacemaker implantation, vascular complications, prosthetic and periprosthetic regurgitation, Karnosfky test and Functional Capacity (FC) were assessed as endpoints.Results:
We evaluated 26 patients with a mean age of 82 years (74% women) in whom 27 procedures were done. The mean Society of Thoracic Surgeons score was 8.8%. Overall mortality at 30 days, one and two years was 11.1, 18.5 and 29.6% respectively. Karnofsky score increased significantly from 62.3% at baseline to 83.9; 88.6 and 88.8% at six months, one and two years, respectively. Prior to the procedure, FC was 3.1 ± 0.6, decreasing significantly to 1.2; 1.3 and 1 at six months, one and two years of follow up.Conclusions:
TAVI is an effective alternative treatment for patients with severe symptomatic AS and high surgical risk.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Ostéoporose
/
Densité osseuse
/
Guides de bonnes pratiques cliniques comme sujet
Type d'étude:
Guide de pratique
/
Étude observationnelle
/
Étude de prévalence
/
Facteurs de risque
Limites du sujet:
Adulte très âgé
/
Femelle
/
Humains
/
Mâle
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2015
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Instituto Nacional del Tórax/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS